Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$42,225,435
-$8,477,469 QoQ
Shares Held
1,753,548
-2.9% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#198
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calamos Advisors LLC holds $812,352,405 across 9 Drug Manufacturers - General names. PFE ranks #6 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
283,001 | $339,439,917 | |
| 2 | JNJ |
Johnson & Johnson
|
647,222 | $164,374,971 | |
| 3 | ABBV |
AbbVie Inc.
|
399,893 | $100,629,074 | |
| 4 | MRK |
Merck & Co., Inc.
|
650,503 | $83,589,635 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
356,488 | $45,038,693 | |
| 6 | PFE |
Pfizer Inc
This page
|
1,753,548 | $42,225,435 | |
| 7 | AMGN |
Amgen Inc
|
68,480 | $24,797,977 | |
| 8 | BIIB |
Biogen Inc.
|
34,879 | $7,535,956 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,225,435 | 1,753,548 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $50,702,904 | 1,805,659 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $47,789,972 | 1,919,276 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $47,401,259 | 1,860,332 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $45,094,447 | 1,860,332 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $45,013,114 | 1,776,366 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $43,577,488 | 1,642,574 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $27,933,843 | 965,233 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $27,669,841 | 988,915 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $37,416,268 | 1,348,334 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $39,536,616 | 1,373,276 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $45,928,177 | 1,384,630 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $50,740,984 | 1,383,342 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $56,413,344 | 1,382,680 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $77,636,388 | 1,515,152 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $75,523,677 | 1,725,861 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $97,699,058 | 1,863,419 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $89,705,917 | 1,732,778 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $91,529,330 | 1,550,031 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $67,404,841 | 1,567,190 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $54,424,685 | 1,389,803 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $41,297,671 | 1,139,875 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $40,992,793 | 1,113,632 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $42,197,104 | 1,149,786 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $46,047,173 | 1,408,169 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $47,934,288 | 1,468,577 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||